FDA Support for Developing Products for Rare Diseases & Conditions

The FDA Office of Orphan Products Development (OOPD) mission is to advance the evaluation and development of products (drugs, biologics, devices, or medical foods) that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions.  In fulfilling that task, OOPD evaluates scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to further advance scientific development of such promising medical products. The office also works on rare disease issues with the medical and research communities, professional organizations, academia, governmental agencies, industry, and rare disease patient groups.Continue reading

Tucson ScienceWorks: Sparking a love for science in future innovators

The impact of science and technology on our lives grows with each passing day. Yet, with so much continually swirling around us, the basic workings of the world we live in have become obscured, its simple beauty hidden.  It’s not that we have given up on being curious. It’s just that for many of us, the world we face seems too complex to understand.Continue reading

Decades of Progress with More to Come

Over four decades ago, President Richard Nixon signed the National Cancer Act and the “War on Cancer” was engaged.  Now as we look at the progress that has been made and the progress yet to come, executives from PhRMA share the recent results of a study released on over 5000 new drugs in the biopharma pipeline that are taking us forward in the war against cancer and other diseases.Continue reading